Effects of Hesperidin on Bone Biomarkers in Postmenopausal Women

PHASE2CompletedINTERVENTIONAL
Enrollment

144

Participants

Timeline

Start Date

October 31, 2007

Primary Completion Date

January 31, 2012

Study Completion Date

January 31, 2012

Conditions
OsteopeniaOsteoporosis
Interventions
OTHER

Hesperidin

250 mg of hesperidin twice a day taken oraly in a biscuit or in milk for 6 months

Trial Locations (1)

56000

Hospital of UKM, National University of Malaysia, Kuala Lumpur

All Listed Sponsors
collaborator

National University of Malaysia

OTHER

lead

Société des Produits Nestlé (SPN)

INDUSTRY

NCT00545116 - Effects of Hesperidin on Bone Biomarkers in Postmenopausal Women | Biotech Hunter | Biotech Hunter